R&D | November 14, 2025
UK MHRA finds gut microbiome research unreliable across labs
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months
These distinct gut microbial signatures can be used to predict the risk of developing long Covid and diagnose long Covid in patients with persistent symptoms after the acute infection
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
Subscribe To Our Newsletter & Stay Updated
